Standard BioTools Terminates Its Previously Announced Agreement To Sell Its Mass Cytometry Business To Multiplex Bio; Co. Enters Into A Definitive Agreement To Sell Its Mass Cytometry Business To Element Biosystems For $5.5M In Cash Payable

Benzinga

2026.09.30 20:45 (GMT+0)

Öffnen unter Benzinga